Issue 5/2003
Content (7 Articles)
Original Research Article
A Simulation Model for Estimating Direct Costs of Type 1 Diabetes Prevention
Jarmo Hahl, Tuula Simell, Antti Kupila, Päivi Keskinen, Mikael Knip, Jorma Ilonen, Olli Simell
Original Research Article
Cost Effectiveness of Alendronate (Fosamax®) for the Treatment of Osteoporosis and Prevention of Fractures
Olof Johnell, Bengt Jönsson, Linus Jönsson, Dennis Black
Original Research Article
The Cost Effectiveness of Two New Antiepileptic Therapies in the Absence of Direct Comparative Data
Ben A. van Hout, Dennis D. Gagnon, Pauline McNulty, Anthony O’Hagan
Original Research Article
Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer’s Disease
Anders Wimo, Bengt Winblad, Albrecht Stöffler, Yvonne Wirth, Hans-Jörg Möbius
Original Research Article
Peginterferon α-2a (40kD) [Pegasys®] Improves HR-QOL Outcomes Compared with Unmodified Interferon α-2a [Roferon®-A]
Jens Rasenack, Stefan Zeuzem, S. Victor Feinman, E. Jenny Heathcote, Michael Manns, Eric M. Yoshida, Mark G. Swain, Edward Gane, Moises Diago, Dennis A. Revicki, Amy Lin, Neil Wintfeld, Jesse Green
Original Research Article
Cost Effectiveness of Nasal Budesonide versus Surgical Treatment for Nasal Polyps
Fredrik Berggren, Leif Johansson
Original Research Article
Factors Affecting UK Primary-Care Costs of Managing Patients with Asthma over 5 Years
Roben Das Gupta, Julian F. Guest